Etidronate in subcutaneous fat necrosis of the newborn [1] (multiple letters)

Journal of Pediatrics

Volumn 135, Issue 4, 1999, Pages 530-531

  Bachrach, L K ^a   Lum, C K ^a   Rice, A M ^a   Rivkees, S A ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCITRIOL; CALCIUM; ETIDRONIC ACID; GLUCOCORTICOID; PYRIDINOLINE;

BONE TURNOVER; DIET THERAPY; DRUG INDICATION; FAT NECROSIS; HUMAN; HYPERCALCEMIA; LETTER; NEWBORN; OSTEOLYSIS; PRIORITY JOURNAL; SUBCUTANEOUS FAT DISORDER;

EID: 0033506409     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(99)70183-6     Document Type: Letter

References (4)

1. AM Rice SA Rivkees Etidronate therapy for hypercalcemia in subcutaneous fat necrosis in the newborn J Pediatr 134 1999 349 351
2. LR Shoemaker Expanding role of bisphosphonate therapy in children J Pediatr 134 1999 264 267
3. CJ Rosen CR Kessenich Comparative clinical pharmacology and therapeutic use of bisphosphonates in metabolic bone diseases Drugs 51 1996 537 551
4. CK Lum I Solomon LK Bachrach Asymptomatic hypercalcemia in subcutaneous fat necrosis Clin Pediatr 38 1999 547 550